audio

Auteur

Azuma Arata

Œuvres

EM703 improves bleomycin-induced pulmonary fibrosis in mice by the inhibition of TGF-β signaling in lung fibroblasts
Category

Documents

EM703 improves bleomycin-induced pulmonary fibrosis in mice by the inhibition of TGF-β signaling in lung fibroblasts

Azuma Arata, Usuki Jiro, Abe Shinji, Matsuda Kuniko, Sunazuka Toshiaki, Shimizu Takako, Hirata Yukiyo, Inagaki Hirofumi, Kawada Tomoyuki, Takahashi Satoru, Kudoh Shoji, Omura Satoshi, Li

EM703 improves bleomycin-induced pulmonary fibrosis in mice by the inhibition of TGF-β signaling in lung fibroblasts Alternate Text
Category

Documents

Savoirs

EM703 improves bleomycin-induced pulmonary fibrosis in mice by the inhibition of TGF-β signaling in lung fibroblasts

Azuma Arata, Usuki Jiro, Abe Shinji, Matsuda Kuniko, Sunazuka Toshiaki, Shimizu Takako, Hirata Yukiyo, Inagaki Hirofumi, Kawada Tomoyuki, Takahashi Satoru, Kudoh Shoji, Omura Satoshi, Li

Book

13 pages

Flag

English

The clinical significance of 5% change in vital capacity in patients with idiopathic pulmonary fibrosis: extended analysis of the pirfenidone trial
Category

Documents

The clinical significance of 5% change in vital capacity in patients with idiopathic pulmonary fibrosis: extended analysis of the pirfenidone trial

Taniguchi Hiroyuki, Kondoh Yasuhiro, Ebina Masahito, Azuma Arata, Ogura Takashi, Taguchi Yoshio, Suga Moritaka, Takahashi Hiroki, Nakata Koichiro, Sato Atsuhiko, Sugiyama Yukihiko, Kudoh Shoji, Nukiwa Toshihiro, Pirfenidone

The clinical significance of 5% change in vital capacity in patients with idiopathic pulmonary fibrosis: extended analysis of the pirfenidone trial Alternate Text
Category

Documents

Savoirs

The clinical significance of 5% change in vital capacity in patients with idiopathic pulmonary fibrosis: extended analysis of the pirfenidone trial

Taniguchi Hiroyuki, Kondoh Yasuhiro, Ebina Masahito, Azuma Arata, Ogura Takashi, Taguchi Yoshio, Suga Moritaka, Takahashi Hiroki, Nakata Koichiro, Sato Atsuhiko, Sugiyama Yukihiko, Kudoh Shoji, Nukiwa Toshihiro, Pirfenidone

Book

9 pages

Flag

English

Exploratory analysis of a phase III trial of pirfenidone identifies a subpopulation of patients with idiopathic pulmonary fibrosis as benefiting from treatment
Category

Documents

Exploratory analysis of a phase III trial of pirfenidone identifies a subpopulation of patients with idiopathic pulmonary fibrosis as benefiting from treatment

Azuma Arata, Taguchi Yoshio, Ogura Takashi, Ebina Masahito, Taniguchi Hiroyuki, Kondoh Yasuhiro, Suga Moritaka, Takahashi Hiroki, Nakata Koichiro, Sato Atsuhiko, Kudoh Shoji, Nukiwa Toshihiro, Pirfenidone

Exploratory analysis of a phase III trial of pirfenidone identifies a subpopulation of patients with idiopathic pulmonary fibrosis as benefiting from treatment Alternate Text
Category

Documents

Savoirs

Exploratory analysis of a phase III trial of pirfenidone identifies a subpopulation of patients with idiopathic pulmonary fibrosis as benefiting from treatment

Azuma Arata, Taguchi Yoshio, Ogura Takashi, Ebina Masahito, Taniguchi Hiroyuki, Kondoh Yasuhiro, Suga Moritaka, Takahashi Hiroki, Nakata Koichiro, Sato Atsuhiko, Kudoh Shoji, Nukiwa Toshihiro, Pirfenidone

Book

11 pages

Flag

English

Alternate Text